Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -0.10% | -0.10% |
16/04 | DNA Oyj Announces Change in the Executive Team | CI |
07/02 | Eltel and DNA Renew One-Year Telecom Frame Agreement in Finland Worth About EUR 12.5 Million | CI |
Sales 2022 | 997M 1.07B 88.92B | Sales 2023 | 1.07B 1.14B 95.16B | Capitalization | 2.75B 2.95B 246B |
---|---|---|---|---|---|
Net income 2022 | 120M 128M 10.7B | Net income 2023 | 146M 156M 13.02B | EV / Sales 2022 | 3.4 x |
Net Debt 2022 | 634M 678M 56.54B | Net Debt 2023 | 670M 717M 59.77B | EV / Sales 2023 | 3.21 x |
P/E ratio 2022 |
22.9
x | P/E ratio 2023 |
18.8
x | Employees | - |
Yield 2022 |
3.65% | Yield 2023 |
2.21% | Free-Float | 98.91% |
Managers | Title | Age | Since |
---|---|---|---|
Jussi Tolvanen
CEO | Chief Executive Officer | 46 | 01/21/01 |
Taneli Ropponen
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Ville Virtanen
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 31/19/31 | |
Director/Board Member | 59 | - | |
Thomas Thyholdt
BRD | Director/Board Member | 49 | - |
- Stock Market
- Equities
- DNA Stock